華領醫藥-B

02552
2.0150.98% ( -0.020 )
延遲 已收盤: 11月20日 16:08:00

股東

全部股東

股東類型

  • 公眾及其他65.27%
  • 創投/私募28.08%
  • 個人與內幕人士5.57%
  • 機構投資者1.09%

主要股東

主要股東 最新
股東
Arch Venture Partners, L.P.
12.53%1.25 億0.00%+031/12/2025
VR Management, LLC
10.36%1.03 億0.00%+031/12/2025
WuXi PharmaTech Healthcare Fund I General Partner L.P.
5.19%5,180.76 萬0.00%+019/06/2025
Li ChenFounder, CEO, Member of Portfolio Advisory Board & Executive Director
4.06%4,053.87 萬0.08%+75.00 萬15/07/2026
Chien Cheng LinExecutive VP, Chief Strategy Officer & Executive Director
0.85%849.93 萬0.00%+031/12/2025
Yi ZhangSenior VP of Pharma Development, Chief Medical Officer – China and Executive Director
0.64%637.50 萬0.00%+031/12/2025
JP Morgan Asset Management
0.53%524.40 萬0.00%+031/12/2025
State Street Investment Management
0.21%207.30 萬<0.01%-2.40 萬30/10/2026
Dimensional Fund Advisors LP
0.17%165.30 萬0.01%+11.75 萬30/10/2026
American Century Investment Management Inc
0.16%161.55 萬0.09%+91.75 萬30/09/2026
China Universal Asset Management Company Ltd.
0.03%31.35 萬0.00%+031/12/2025
Robert Taylor NelsenNon-Executive Chairman
0.02%15.00 萬0.00%+031/12/2025
Yiu Wa TsuiIndependent Non-Executive Director
<0.01%2.40 萬0.00%+031/12/2025
CIBC Asset Management Inc.
<0.01%6,000.000.00%+030/06/2026
E Fund Management Co., Ltd.
<0.01%217.000.00%+031/12/2025